Bone remodeling is performed by osteoclasts and osteoblasts at the bone surface. Inside of bone is a network of numerous osteocytes, whose specific function has remained an enigma. Here we describe a transgenic mouse model in which inducible and specific ablation of osteocytes is achieved in vivo through targeted expression of diphtheria toxin (DT) receptor. Following a single injection of DT, approximately 70%-80% of the osteocytes, but apparently no osteoblasts, were killed. Osteocyte-ablated mice exhibited fragile bone with intracortical porosity and microfractures, osteoblastic dysfunction, and trabecular bone loss with microstructural deterioration and adipose tissue proliferation in the marrow space, all of which are hallmarks of the aging skeleton. Strikingly, these "osteocyte-less" mice were resistant to unloading-induced bone loss, providing evidence for the role of osteocytes in mechanotransduction. Thus, osteocytes represent an attractive target for the development of diagnostics and therapeutics for bone diseases, such as osteoporosis.
Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Publishing Authors By Initials
Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Cell metabolism
VOLUME: 5
Page Numbers: 464-75
Journal Abbreviation: Cell Metab.
ISSN: 1550-4131
DAY: 6
MONTH: Jun
YEAR: 2007
Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 101233170
Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction.
AFFILIATION: Department of Bone and Joint Disease, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi 474-8522, Japan; National Institute of Biomedical Innovation, Osaka 567-0085, Japan.
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Cell Metab
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction Related Publications